Centessa Pharmaceuticals PLC ADR (CNTA) — Financial Flexibility Index
Centessa Pharmaceuticals PLC ADR (CNTA) has a Financial Flexibility Index of -0.47x as of March 2026. Free cash flow of $-72.22 Million (operating CF $-72.22 Million minus capex $0.00) represents 0% of total liabilities ($154.41 Million). Check Centessa Pharmaceuticals PLC ADR tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Centessa Pharmaceuticals PLC ADR Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Centessa Pharmaceuticals PLC ADR across 7 annual periods. For the full cash flow conversion analysis, see CNTA cash generation efficiency.
Annual Financial Flexibility Index for Centessa Pharmaceuticals PLC ADR (2019–2025)
Year-by-year free cash flow to debt coverage for Centessa Pharmaceuticals PLC ADR. Explore CNTA operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.20x | $-193.45 Million | $-193.82 Million | $160.63 Million | ▼ -48.6% |
| 2024 | -0.81x | $-142.02 Million | $-142.06 Million | $175.25 Million | ▲ +37.3% |
| 2023 | -1.29x | $-160.17 Million | $-160.34 Million | $124.00 Million | ▲ +30.0% |
| 2022 | -1.84x | $-199.41 Million | $-200.55 Million | $108.14 Million | ▼ -87.3% |
| 2021 | -0.98x | $-135.96 Million | $-136.14 Million | $138.08 Million | ▲ +18.7% |
| 2020 | -1.21x | $-10.44 Million | $-10.63 Million | $8.62 Million | ▼ -30.3% |
| 2019 | -0.93x | $-5.64 Million | $-5.83 Million | $6.07 Million | — |